Earningsreport

Q3/2025 9/30/2025 EPS -0.870 ZacksConsensus -0.510 ActVsEst (0.360) - Miss

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx